One of the youngest fund managers in the U.S. just launched her own accelerator, too

Last August, we told you about Laura Deming, a New Zealand native who was home schooled before moving halfway around the world as a 12-year-old to work alongside Cynthia Kenyon, a renowned molecular

Biomedical startup AesculaTech is creating a new, more patient-friendly drug delivery system

“Reverse chocolate” — that’s how AesculaTech co-founder and chief science officer Niki Bayat describes the material created by its proprietary technology. Chocolate is solid until heated, when

Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks

Developing new medicines can take years of research and cost millions of dollars before they are even ready for clinical trials. Several biotech startups are using machine learning to revolutionize th

Corporate bio VCs are backing more rounds and making bigger bets

Biotech is a lot like venture capital. Vast amounts of research, testing and marketing go into a wide range of therapies. But in the end, it’s just a tiny fraction that deliver most returns. That si

Life sciences startup Avro aims to deliver drugs to children and the elderly through skin patches

Avro, a life sciences startup in Y Combinator’s current batch, is banking on a method to deliver medications to populations unable to swallow or chew — it will administer them through the

US-China biotech startup XtalPi lands $15M from Google, Tencent and Sequoia

Google continues to increase its presence in China after it joined Sequoia China and Tencent in a $15 million investment for XtalPi, a U.S.-China biotech firm that uses artificial intelligence and co

Startup fundraising and exits look bullish for bio and health

After nearly a year, venture capitalists nabbed their first U.S. acquisition for more than a billion dollars. And it wasn’t a tech startup. Nor was it a company on the list of known unicorns. And i

GV co-leads $27.1M Series A in Oxford Uni life sciences spinout Vaccitech

Leaning on its in-house life sciences expertise GV has backed another biotech startup in the UK, co-leading a £20 million ($27.1M) Series A in Oxford University spinout Vaccitech, which is developin

Y Combinator is launching a biotech track

Y Combinator is pulling the curtains off of a new experiment, YC Bio. The idea is to fund early-stage life-sciences companies that are still in the lab phase, YC President Sam Altman wrote on the YC b

Spider silk startup Bolt Threads closes on $123 million in Series D funding

Bolt Threads, the startup making spider silk from microbugs, has raised a giant $123 million Series D round of funding. As we reported in November, an SEC filing showed the company had raised $106 m

Malicious code written into DNA infects the computer that reads it

In a mind-boggling world first, a team of biologists and security researchers have successfully infected a computer with a strand of DNA. It sounds like science fiction, but it's very real — althoug

Synthego’s genetic toolkit aims to make CRISPR more accessible

We hear a lot about the potential and implications of the gene-editing technique CRISPR, but it's not like just anyone can open up an app, pick a gene they don't like, and build the molecular machiner

SpyBiotech, which makes a ‘superglue’ for vaccines, raises £4M from GV and Oxford

The startup bug has hit the world of biotechnology, and the latest victim is a business that is building a "super glue," coincidentally, for bug-combating vaccines. SpyBiotech -- a startup spun out of

Booze investors favor apps, gadgets and biotech

Archaeological records show humans have been making alcohol since at least 7000 BC. We figured out wine more than 6,000 years ago. By the time the ancient Egyptians entered the scene, brewers were mak

CRV just put advanced bioengineering on its shopping list

CRV, an early-stage venture firm that made headlines last year for its stance on then-candidate Donald Trump's campaign, is looking to get out a new (non-political) message: It's diving more deeply in

Crunch Report | AppDynamics CEO Talks Cisco Acquisition

AppDynamics CEO David Wadhwani and Cisco VP of IoT Rowan Trollope talk to us about the $3.7 billion acquisition, Alpahbet biotech moonshot lands $800 million in funding and a Snapchat Spectacles case

Breakout Labs backs 4 startups that are “reprogramming nature”

A venture fund that backs very early-stage advanced tech and science startups, Breakout Labs, has invested in 4 new deals, according to founder and Managing Partner Lindy Fishburne. The fund, which is

Bioscience meets AI — Dr. Jackie Hunter of BenevolentAI to speak at Disrupt London

Disrupt hits London December 5-6 and it is our pleasure to announce that Dr. Jackie Hunter, Board Director of BenevolentAI and CEO of BenevolentBio, will be joining us as one of our featured speakers

Theranos closes its labs and wellness centers, lays off 340

Theranos is closing its labs and wellness centers, CEO Elizabeth Holmes announced today in blog post. And this isn't a temporary closure: the "approximately" 340 employees running them are out of a jo

Amaryllis Nucleics makes transcribing genes quicker, better and cheaper

The ability to read and record genes sits at the base (base pair, if you will) of biotech companies worldwide. So improvements to that ability are kind of like upgrading the specs of the industry itse
Load More